The Tobacco Regulatory Science Program (TRSP) is an interagency partnership between the NIH and the FDA Center for Tobacco Products to foster tobacco regulatory research.
With the passage of the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. Within the framework of the Tobacco Control Act, the NIH and FDA formed this partnership to establish a comprehensive research agenda in tobacco regulatory science.
- TRSP intends to reissue the K01 and the K99/R00 RFAs in Spring 2020.
- The Tobacco Regulatory Science R01 has been reissued with new research priorities.
- New R21 RFAs support research using existing datasets and biospecimen collections.
- Selected resources are available for FOAs including FAQs and recorded pre-application webinars.
TRSP encourages research applications that address the FDA's research priorities to better understand toxicity, addiction, and appeal of tobacco products.
On August 15 the FDA issued a proposed new rule to require color graphic health warnings for cigarette packaging and advertisements.
An NIH-FDA partnership to foster tobacco regulatory research.
Research projects on tobacco regulatory research funded through TRSP.
Active funding announcements and application information.
Research topic and project priorities for TRSP funding announcements.
Research tools, publications, statistics, and announcements.